AU2003272973A1 - Method for treatment of cancer - Google Patents
Method for treatment of cancerInfo
- Publication number
- AU2003272973A1 AU2003272973A1 AU2003272973A AU2003272973A AU2003272973A1 AU 2003272973 A1 AU2003272973 A1 AU 2003272973A1 AU 2003272973 A AU2003272973 A AU 2003272973A AU 2003272973 A AU2003272973 A AU 2003272973A AU 2003272973 A1 AU2003272973 A1 AU 2003272973A1
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41764302P | 2002-10-11 | 2002-10-11 | |
| US60/417,643 | 2002-10-11 | ||
| PCT/JP2003/013047 WO2004032931A1 (en) | 2002-10-11 | 2003-10-10 | Method for treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003272973A1 true AU2003272973A1 (en) | 2004-05-04 |
Family
ID=32094054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003272973A Abandoned AU2003272973A1 (en) | 2002-10-11 | 2003-10-10 | Method for treatment of cancer |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003272973A1 (en) |
| WO (1) | WO2004032931A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008045663A2 (en) * | 2006-10-06 | 2008-04-17 | Kalypsys, Inc. | Aryl-substituted heterocyclic pde4 inhibitors as antiinflammatory agents |
| CN104418800B (en) * | 2013-09-06 | 2017-06-16 | 沈阳中化农药化工研发有限公司 | Aryl pyrrole (phonetic) pyridine class compound and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3808921B2 (en) * | 1995-11-20 | 2006-08-16 | 興和株式会社 | Cell adhesion inhibitor |
| AU2001238424A1 (en) * | 2000-02-18 | 2001-08-27 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
| US6509329B1 (en) * | 2001-06-29 | 2003-01-21 | Kowa Co., Ltd. | Cyclic diamine compound with 6-membered ring groups |
| US6432957B1 (en) * | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
| US6552188B2 (en) * | 2001-06-29 | 2003-04-22 | Kowa Co., Ltd. | Unsymmetrical cyclic diamine compound |
| EP1441683A4 (en) * | 2001-10-12 | 2005-10-26 | Univ New York | Trisubstituted triazine compounds, and methods for making an using the compounds, which have antitubulin activity |
-
2003
- 2003-10-10 WO PCT/JP2003/013047 patent/WO2004032931A1/en not_active Application Discontinuation
- 2003-10-10 AU AU2003272973A patent/AU2003272973A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004032931A1 (en) | 2004-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003226301A1 (en) | Method of treating cancer | |
| AU2003256847A1 (en) | Method of treating cancer | |
| AU2003224788A1 (en) | Method for treatment of tissue | |
| AU2003293333A1 (en) | Method of treating cancers | |
| AU2003213771A1 (en) | Method for modification of radiotherapy treatment delivery | |
| AU2003259249A1 (en) | Pyridazinylpiperazine derivatives for treating pain | |
| AU2003281076A1 (en) | Process for treatment of underground reservoirs | |
| AU2002328952A1 (en) | Irinotecan for treatment of cancer | |
| AU2002359950A1 (en) | Plasma treatment method | |
| AU2003280558A1 (en) | Method for treatment of cancer | |
| AU2003223538A1 (en) | Methods for the treatment of cancer | |
| AU2003233820A1 (en) | Method for the treatment of starch | |
| AU2003222449A1 (en) | Medicine for treating cancer | |
| AU2002308642A1 (en) | Methods for treating cancer | |
| AU2003218188A1 (en) | Method of treating onychomycosis | |
| AU2003259833A1 (en) | Methods of treating neurodegenerative diseases | |
| AU2003221005A1 (en) | Method of wastewater treatment | |
| AU2003272972A1 (en) | Method of treatment for cancer | |
| AU2003296242A1 (en) | Thia-epothilone derivatives for the treatment of cancer | |
| AU2002951913A0 (en) | Method of treatment | |
| AU2003272973A1 (en) | Method for treatment of cancer | |
| AU2003248584A1 (en) | Method of treating osteoarthritis | |
| AUPR731901A0 (en) | Method of treatment | |
| AU2003252188A1 (en) | Method of ore treatment | |
| AU2003236232A1 (en) | Method for treatment of textile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |